{"pmid":32290887,"title":"COVID-19: What Paramedics Need to Know!","text":["COVID-19: What Paramedics Need to Know!","CJEM","Buick, Jason E","Cheskes, Sheldon","Feldman, Michael","Verbeek, P Richard","Hillier, Morgan","Leong, Yuen Chin","Drennan, Ian R","32290887"],"journal":"CJEM","authors":["Buick, Jason E","Cheskes, Sheldon","Feldman, Michael","Verbeek, P Richard","Hillier, Morgan","Leong, Yuen Chin","Drennan, Ian R"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32290887","week":"202016|Apr 13 - Apr 19","doi":"10.1017/cem.2020.367","source":"PubMed","topics":["Transmission","Diagnosis","Prevention","Treatment"],"weight":1,"_version_":1664266295608082432,"score":8.233237,"similar":[{"pmid":32171952,"pmcid":"PMC7102543","title":"The SARS-CoV-2 outbreak: what we know.","text":["The SARS-CoV-2 outbreak: what we know.","There is a current worldwide outbreak of the novel coronavirus Covid-19 (coronavirus disease 2019; the pathogen called SARS-CoV-2; previously 2019-nCoV), which originated from Wuhan in China and has now spread to 6 continents including 66 countries, as of 24:00 on March 2, 2020. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak site and from laboratories supporting the investigation. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of coronavirus.","Int J Infect Dis","Wu, Di","Wu, Tiantian","Liu, Qun","Yang, Zhicong","32171952"],"abstract":["There is a current worldwide outbreak of the novel coronavirus Covid-19 (coronavirus disease 2019; the pathogen called SARS-CoV-2; previously 2019-nCoV), which originated from Wuhan in China and has now spread to 6 continents including 66 countries, as of 24:00 on March 2, 2020. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak site and from laboratories supporting the investigation. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of coronavirus."],"journal":"Int J Infect Dis","authors":["Wu, Di","Wu, Tiantian","Liu, Qun","Yang, Zhicong"],"date":"2020-03-16T11:00:00Z","year":2020,"_id":"32171952","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.ijid.2020.03.004","keywords":["Clinical features","CoVID-19","Diagnosis","Epidemiology","Managements strategies","SARS-CoV-2","Treatments","coronavirus"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1663352133934645249,"score":78.96151},{"pmid":32255507,"title":"COVID-19 And Older Adults: What We Know.","text":["COVID-19 And Older Adults: What We Know.","SARS-CoV-2, a novel virus that causes COVID-19 infection, has recently emerged and caused a deadly pandemic. Studies have shown that this virus causes worse outcomes and a higher mortality rate in older adults and those with comorbidities such as hypertension, cardiovascular disease, diabetes, chronic respiratory disease, and chronic kidney disease. A significant percentage of older American adults have these diseases, putting them at a higher risk of infection. Additionally, many adults with hypertension, diabetes, and chronic kidney disease are placed on angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). Studies have shown that these medications upregulate the ACE-2 receptor, the very receptor which the SARS-CoV-2 virus uses to enter host cells, which puts older adults at a further increased risk of infection. In this review, we discuss the transmission, symptomatology, mortality, and possible treatments for this infection, as they relate to older adults. This article is protected by copyright. All rights reserved.","J Am Geriatr Soc","Shahid, Zainab","Kalayanamitra, Ricci","McClafferty, Brendan","Kepko, Douglas","Ramgobin, Devyani","Patel, Ravi","Aggarwal, Chander Shekher","Vunnam, Rama Rao","Sahu, Nitasa","Bhatt, Dhirisha","Jones, Kirk","Golamari, Reshma","Jain, Rohit","32255507"],"abstract":["SARS-CoV-2, a novel virus that causes COVID-19 infection, has recently emerged and caused a deadly pandemic. Studies have shown that this virus causes worse outcomes and a higher mortality rate in older adults and those with comorbidities such as hypertension, cardiovascular disease, diabetes, chronic respiratory disease, and chronic kidney disease. A significant percentage of older American adults have these diseases, putting them at a higher risk of infection. Additionally, many adults with hypertension, diabetes, and chronic kidney disease are placed on angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). Studies have shown that these medications upregulate the ACE-2 receptor, the very receptor which the SARS-CoV-2 virus uses to enter host cells, which puts older adults at a further increased risk of infection. In this review, we discuss the transmission, symptomatology, mortality, and possible treatments for this infection, as they relate to older adults. This article is protected by copyright. All rights reserved."],"journal":"J Am Geriatr Soc","authors":["Shahid, Zainab","Kalayanamitra, Ricci","McClafferty, Brendan","Kepko, Douglas","Ramgobin, Devyani","Patel, Ravi","Aggarwal, Chander Shekher","Vunnam, Rama Rao","Sahu, Nitasa","Bhatt, Dhirisha","Jones, Kirk","Golamari, Reshma","Jain, Rohit"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32255507","week":"202015|Apr 06 - Apr 12","doi":"10.1111/jgs.16472","keywords":["COVID-19","Coronavirus","Mortality","Older Adults","SARS-CoV-2"],"source":"PubMed","locations":["American"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Transmission","Diagnosis","Treatment"],"weight":1,"_version_":1663450393559957504,"score":74.17299},{"pmid":32115733,"title":"Coronavirus disease (COVID-19) and neonate: What neonatologist need to know.","text":["Coronavirus disease (COVID-19) and neonate: What neonatologist need to know.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cause china epidemics with high morbidity and mortality, the infection has been transmitted to other countries. About three neonates and more than 230 children cases are reported. The disease condition of the main children was mild. There is currently no evidence that SARS-CoV-2 can be transmitted transplacentally from mother to the newborn. The treatment strategy for children with Coronavirus disease (COVID-19) is based on adult experience. Thus far, no deaths have been reported in the pediatric age group. This review describes the current understanding of COVID-19 infection in newborns and children.","J Med Virol","Lu, Qi","Shi, Yuan","32115733"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cause china epidemics with high morbidity and mortality, the infection has been transmitted to other countries. About three neonates and more than 230 children cases are reported. The disease condition of the main children was mild. There is currently no evidence that SARS-CoV-2 can be transmitted transplacentally from mother to the newborn. The treatment strategy for children with Coronavirus disease (COVID-19) is based on adult experience. Thus far, no deaths have been reported in the pediatric age group. This review describes the current understanding of COVID-19 infection in newborns and children."],"journal":"J Med Virol","authors":["Lu, Qi","Shi, Yuan"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32115733","week":"202010|Mar 02 - Mar 08","doi":"10.1002/jmv.25740","source":"PubMed","locations":["china"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Transmission"],"weight":1,"_version_":1663352134345687040,"score":72.742714},{"pmid":32273490,"title":"Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?","text":["Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?","Pediatric coronavirus disease - 19 (COVID-19) infection is relatively mild when compared to adults, and children are reported to have a better prognosis. Mortality in children appears rare. Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute to transmission. It remains unclear why children and young adults are less severely affected than older individuals, but this might involve differences in immune system function in the elderly and/or differences in the expression/function of the cellular receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Angiotensin converting enzyme 2 (ACE2). Laboratory findings and chest imaging may not be specific in children with COVID-19. Diagnosis is by Reverse transcriptase-Polymerase chain reaction (RT-PCR) testing of upper or lower respiratory tract secretions. This review additionally considers COVID-19 in immunosuppressed children, and also suggests a management algorithm for the few children who appear to present with life threatening infection, including the potential use of antiviral and immunomodulatory treatment. The most significant threat to global child health from SARS-CoV-2 is unlikely to be related to COVID 19 in children, but rather the socio-economic consequences of a prolonged pandemic.","Indian Pediatr","Balasubramanian, S","Rao, Neha Mohan","Goenka, Anu","Roderick, Marion","Ramanan, Athimalaipet V","32273490"],"abstract":["Pediatric coronavirus disease - 19 (COVID-19) infection is relatively mild when compared to adults, and children are reported to have a better prognosis. Mortality in children appears rare. Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute to transmission. It remains unclear why children and young adults are less severely affected than older individuals, but this might involve differences in immune system function in the elderly and/or differences in the expression/function of the cellular receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Angiotensin converting enzyme 2 (ACE2). Laboratory findings and chest imaging may not be specific in children with COVID-19. Diagnosis is by Reverse transcriptase-Polymerase chain reaction (RT-PCR) testing of upper or lower respiratory tract secretions. This review additionally considers COVID-19 in immunosuppressed children, and also suggests a management algorithm for the few children who appear to present with life threatening infection, including the potential use of antiviral and immunomodulatory treatment. The most significant threat to global child health from SARS-CoV-2 is unlikely to be related to COVID 19 in children, but rather the socio-economic consequences of a prolonged pandemic."],"journal":"Indian Pediatr","authors":["Balasubramanian, S","Rao, Neha Mohan","Goenka, Anu","Roderick, Marion","Ramanan, Athimalaipet V"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32273490","week":"202015|Apr 06 - Apr 12","source":"PubMed","topics":["Treatment","Diagnosis","Mechanism","Transmission"],"weight":1,"_version_":1663712077842219008,"score":71.26891},{"pmid":32226946,"pmcid":"PMC7086482","title":"COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't.","text":["COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't.","Microbiol Aust","Mackenzie, John S","Smith, David W","32226946"],"journal":"Microbiol Aust","authors":["Mackenzie, John S","Smith, David W"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32226946","week":"202014|Mar 30 - Apr 05","doi":"10.1071/MA20013","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission","Diagnosis","Treatment"],"weight":1,"_version_":1663352135228588032,"score":67.93808}]}